Medicure Inc. (OTCMKTS:MCUJF) Short Interest Update

Medicure Inc. (OTCMKTS:MCUJF) saw a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 7 shares, a drop of 99.9% from the July 15th total of 5,660 shares. Based on an average daily volume of 4,968 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Medicure Price Performance

OTCMKTS MCUJF remained flat at $0.85 on Tuesday. The company’s 50 day moving average price is $0.76 and its 200 day moving average price is $0.81. Medicure has a 1-year low of $0.67 and a 1-year high of $0.97. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.04 and a quick ratio of 0.73. The stock has a market cap of $8.87 million, a price-to-earnings ratio of -1.81 and a beta of 0.99.

Medicure (OTCMKTS:MCUJF) last issued its quarterly earnings results on Thursday, May 21st. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.01. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.The business had revenue of $5.79 million during the quarter, compared to analysts’ expectations of $3.63 million.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.